| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.300 | Biomarker | disease | CTD_human | Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro. | 15993441 | 2005 | ||||
|
0.300 | Biomarker | disease | CTD_human | Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. | 15590663 | 2005 | ||||
|
0.300 | Biomarker | disease | CTD_human | Peroxisomal proliferation protects from beta-amyloid neurodegeneration. | 16204253 | 2005 | ||||
|
0.300 | Biomarker | disease | CTD_human | Impaired modulation of GABAergic transmission by muscarinic receptors in a mouse transgenic model of Alzheimer's disease. | 12746438 | 2003 | ||||
|
0.300 | Biomarker | disease | CTD_human | Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: anti-apoptosis by alpha-2-adrenergic receptor activation. | 12852432 | 2003 | ||||
|
0.300 | Biomarker | disease | CTD_human | Copper reduction by copper binding proteins and its relation to neurodegenerative diseases. | 12572668 | 2003 | ||||
|
0.300 | Biomarker | disease | CTD_human | Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). | 12192006 | 2002 | ||||
|
0.300 | Biomarker | disease | CTD_human | Vitamin E protects nerve cells from amyloid beta protein toxicity. | 1497677 | 1992 | ||||
|
0.300 | Biomarker | disease | CTD_human | Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. | 1671712 | 1991 | ||||
|
0.300 | Biomarker | disease | CTD_human | Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. | 1678058 | 1991 |